241 related articles for article (PubMed ID: 3001182)
1. Targeting of drug loaded immunoliposomes to herpes simplex virus infected corneal cells: an effective means of inhibiting virus replication in vitro.
Norley SG; Huang L; Rouse BT
J Immunol; 1986 Jan; 136(2):681-5. PubMed ID: 3001182
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of herpes simplex virus replication in the mouse cornea by drug containing immunoliposomes.
Norley SG; Sendele D; Huang L; Rouse BT
Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):591-5. PubMed ID: 3030960
[TBL] [Abstract][Full Text] [Related]
3. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
4. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
Désormeaux A; Bergeron MG
Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
[TBL] [Abstract][Full Text] [Related]
5. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of acyclovir-induced suppression of HSV-1 replication in rabbit corneal cells.
Rong BL; Dunkel EC; Pavan-Langston D
Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):928-32. PubMed ID: 2836333
[TBL] [Abstract][Full Text] [Related]
7. Interactions of target-sensitive immunoliposomes with herpes simplex virus. The foundation of a sensitive immunoliposome assay for the virus.
Ho RJ; Rouse BT; Huang L
J Biol Chem; 1987 Oct; 262(29):13979-84. PubMed ID: 2820988
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
[TBL] [Abstract][Full Text] [Related]
9. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
[TBL] [Abstract][Full Text] [Related]
10. Rose bengal inhibits herpes simplex virus replication in vero and human corneal epithelial cells in vitro.
Chodosh J; Banks MC; Stroop WG
Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2520-7. PubMed ID: 1321799
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of immunoliposomes for targeting of antiviral agents.
Kalvakolanu DV; Abraham A
Biotechniques; 1991 Aug; 11(2):218-22, 224-5. PubMed ID: 1931020
[TBL] [Abstract][Full Text] [Related]
12. Target-sensitive immunoliposomes as an efficient drug carrier for antiviral activity.
Ho RJ; Rouse BT; Huang L
J Biol Chem; 1987 Oct; 262(29):13973-8. PubMed ID: 2820987
[TBL] [Abstract][Full Text] [Related]
13. Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell.
Braun RW; Teute HK; Kirchner H; Munk K
J Immunol; 1984 Feb; 132(2):914-9. PubMed ID: 6317753
[TBL] [Abstract][Full Text] [Related]
14. Destabilization of target-sensitive immunoliposomes by antigen binding--a rapid assay for virus.
Ho RJ; Rouse BT; Huang L
Biochem Biophys Res Commun; 1986 Jul; 138(2):931-7. PubMed ID: 3017345
[TBL] [Abstract][Full Text] [Related]
15. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection.
Cheng H; Tumpey TM; Staats HF; van Rooijen N; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1402-9. PubMed ID: 10798656
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immunity to herpes simplex virus: induction of cytotoxic T lymphocyte responses by viral antigens incorporated into liposomes.
Lawman MJ; Naylor PT; Huang L; Courtney RJ; Rouse BT
J Immunol; 1981 Jan; 126(1):304-8. PubMed ID: 6969745
[TBL] [Abstract][Full Text] [Related]
17. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication.
Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P
Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682
[TBL] [Abstract][Full Text] [Related]
18. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
[TBL] [Abstract][Full Text] [Related]
19. Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells.
Van Vliet KE; De Graaf-Miltenburg LA; Verhoef J; Van Strijp JA
Immunology; 1992 Sep; 77(1):109-15. PubMed ID: 1328043
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein D homologs in herpes simplex virus type 1, pseudorabies virus, and bovine herpes virus type 1 bind directly to human HveC(nectin-1) with different affinities.
Connolly SA; Whitbeck JJ; Rux AH; Krummenacher C; van Drunen Littel-van den Hurk S; Cohen GH; Eisenberg RJ
Virology; 2001 Feb; 280(1):7-18. PubMed ID: 11162814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
